Biopharma News

Nov 04, 2014
By BioPharm International Editors
AstraZeneca announced a partnership with Pharmacyclics and Janssen for combination trials of MEDI4736 (AstraZeneca) with Imbruvica (Pharmacyclics and Janssen) for the treatment of hematologic cancers.
Nov 04, 2014
Amgen wants the regulatory agency to ensure biosimilar applicants follow the rules of the patent dispute resolution process delineated by the BPCIA.
Nov 04, 2014
By BioPharm International Editors
Construction has started on Novo Nordisk's laboratories for diabetes research in Denmark.
Nov 03, 2014
By BioPharm International Editors
Bristol-Myers Squibb announced a multi-year expansion of its biologics manufacturing agreement with Lonza.
Nov 03, 2014
By BioPharm International Editors
Bristol-Myers Squibb entered into an agreement with Galecto Biotech AB to gain exclusive rights to TD139, a novel inhaled inhibitor of galectin-3 for the treatment of idiopathic pulmonary fibrosis.
Oct 29, 2014
By BioPharm International Editors
The new Argos biomanufacturing facility in North Carolina will include automated production using the company's Arcelis technology.
Oct 29, 2014
By BioPharm International Editors
Bristol-Myers Squibb announced that they have reached an agreement with F-star Alpha, giving BMS the exclusive option to acquire F-star's HER2-targeted breast and gastric cancer treatment.
Oct 28, 2014
New research will focus on a superfamily of protein receptors linked to various diseases.
Oct 28, 2014
The Yale School of Medicine and Gilead will continue their research on cancer targets for a minimum of three additional years.
Oct 27, 2014
Two lots of empty intravenous fluid bags were voluntarily recalled because of the presence of particulates.
native1_300x100
lorem ipsum